Gunther Birznieks Vanda Pharmaceuticals Inc. (VNDA) insider trading activity

Gunther Birznieks is SVP, Business Development of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 438,569 shares of VNDA, which is worth approximately $1.94 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 125,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 439K

39.86% 3M change

32.51% 12M change

Total Value Held $1.94 Million

Gunther Birznieks Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	BUY Grant, award, or other acquisition	-	125,000 Added 22.18%	438,569 Common Stock
Mar 05 2024	SELL Open market or private sale	$35,864 $4.13 p/Share	8,684 Reduced 2.69%	313,569 Common Stock
Mar 04 2024	SELL Open market or private sale	$37,526 $4.3 p/Share	8,727 Reduced 2.64%	322,253 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	125,000 Added 27.41%	330,980 Common Stock
Mar 03 2023	SELL Open market or private sale	$51,757 $6.26 p/Share	8,268 Reduced 3.86%	205,980 Common Stock
Mar 02 2023	SELL Open market or private sale	$52,755 $6.2 p/Share	8,509 Reduced 3.82%	214,248 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	32,700 Added 12.8%	222,757 Common Stock
Aug 26 2022	BUY Exercise of conversion of derivative security	$3,900 $3.12 p/Share	1,250 Added 0.65%	190,057 Common Stock
Mar 02 2022	SELL Open market or private sale	$129,797 $11.27 p/Share	11,517 Reduced 5.75%	188,807 Common Stock
Mar 01 2022	SELL Open market or private sale	$45,700 $11.19 p/Share	4,084 Reduced 2.0%	200,324 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	32,700 Added 13.79%	204,408 Common Stock
Mar 02 2021	SELL Open market or private sale	$302,318 $18.19 p/Share	16,620 Reduced 8.83%	171,708 Common Stock
Mar 01 2021	SELL Open market or private sale	$71,748 $18.66 p/Share	3,845 Reduced 2.0%	188,328 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	32,700 Added 14.54%	192,173 Common Stock

Gunther Birznieks

SVP, Business Development

Washington, DC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Value

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vanda Pharmaceuticals Inc.

Track Activities on VNDA

Account